Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Higa

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
The West Virginia Medical Journal|July 1, 1995
Scientific publications and scientific styleG M Higa
The Annals of Pharmacotherapy|January 1, 1994
Significance of granulocyte colony-stimulating factor (G-CSF)-induced increases in LDHG M Higa
American Journal of Pharmaceutical Education|December 7, 2006
Guidelines are not mandatesGerald M Higa
Expert Opinion on Pharmacotherapy|September 19, 2009
Breast cancer: beyond the cutting edgeGerald M Higa
Translational Cancer Research|December 22, 2023
HER destiny tooGerald M Higa
Expert Opinion on Pharmacotherapy|October 5, 2001
Aromatase inhibitors for breast cancer: pharmacoeconomic considerationsG M Higa
Pharmacoeconomics|August 18, 2000
New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefitsG M Higa
Expert Review of Anticancer Therapy|January 30, 2004
Targeted therapies in oncology: in the crosshairs or at the crossroads?Gerald M Higa
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
An engineering feat of small proportionsGerald M Higa
American Journal of Hospital Pharmacy|December 1, 1993
Difficulties in assessing appropriate ondansetron useG M Higa
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
The West Virginia Medical Journal|July 1, 1995
Scientific publications and scientific styleG M Higa
The Annals of Pharmacotherapy|January 1, 1994
Significance of granulocyte colony-stimulating factor (G-CSF)-induced increases in LDHG M Higa
American Journal of Pharmaceutical Education|December 7, 2006
Guidelines are not mandatesGerald M Higa
Expert Opinion on Pharmacotherapy|September 19, 2009
Breast cancer: beyond the cutting edgeGerald M Higa
Translational Cancer Research|December 22, 2023
HER destiny tooGerald M Higa
Expert Opinion on Pharmacotherapy|October 5, 2001
Aromatase inhibitors for breast cancer: pharmacoeconomic considerationsG M Higa
Pharmacoeconomics|August 18, 2000
New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefitsG M Higa
Expert Review of Anticancer Therapy|January 30, 2004
Targeted therapies in oncology: in the crosshairs or at the crossroads?Gerald M Higa
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
An engineering feat of small proportionsGerald M Higa
American Journal of Hospital Pharmacy|December 1, 1993
Difficulties in assessing appropriate ondansetron useG M Higa
Pageof 17